anmelden
NYSE International 100
10.609,65
PKT
-6,77
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.24 | Sanofi Overweight | Barclays Capital | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.01.24 | Philips Equal-weight | Morgan Stanley | |
| 08.01.24 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.24 | UBS Outperform | RBC Capital Markets | |
| 05.01.24 | Deutsche Bank Outperform | RBC Capital Markets | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | TotalEnergies Overweight | Barclays Capital | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.01.24 | Eni Overweight | Barclays Capital | |
| 04.01.24 | SAP Overweight | Barclays Capital | |
| 04.01.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 04.01.24 | TotalEnergies Sector Perform | RBC Capital Markets | |
| 04.01.24 | Eni Sector Perform | RBC Capital Markets | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 04.01.24 | Siemens Outperform | Bernstein Research | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | Siemens Underweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Mercedes-Benz Group (ex Daimler) Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.01.24 | Nokia Neutral | UBS AG | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital |